Logo image of PEN

PENUMBRA INC (PEN) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:PEN - US70975L1070 - Common Stock

291.66 USD
-1.51 (-0.52%)
Last: 12/1/2025, 4:10:00 PM
291.66 USD
0 (0%)
After Hours: 12/1/2025, 4:10:00 PM
Fundamental Rating

6

Overall PEN gets a fundamental rating of 6 out of 10. We evaluated PEN against 188 industry peers in the Health Care Equipment & Supplies industry. While PEN has a great health rating, its profitability is only average at the moment. PEN is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes PEN very considerable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

PEN had positive earnings in the past year.
In the past year PEN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: PEN reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: PEN reported negative operating cash flow in multiple years.
PEN Yearly Net Income VS EBIT VS OCF VS FCFPEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

PEN has a Return On Assets of 9.40%. This is amongst the best in the industry. PEN outperforms 91.49% of its industry peers.
PEN has a better Return On Equity (12.07%) than 88.30% of its industry peers.
PEN's Return On Invested Capital of 7.37% is amongst the best of the industry. PEN outperforms 82.45% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PEN is significantly below the industry average of 8.72%.
The 3 year average ROIC (2.98%) for PEN is below the current ROIC(7.37%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.4%
ROE 12.07%
ROIC 7.37%
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
PEN Yearly ROA, ROE, ROICPEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

1.3 Margins

PEN's Profit Margin of 12.30% is amongst the best of the industry. PEN outperforms 88.30% of its industry peers.
PEN's Profit Margin has declined in the last couple of years.
PEN has a Operating Margin of 12.95%. This is amongst the best in the industry. PEN outperforms 80.32% of its industry peers.
In the last couple of years the Operating Margin of PEN has declined.
PEN has a Gross Margin of 66.80%. This is in the better half of the industry: PEN outperforms 69.68% of its industry peers.
PEN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.95%
PM (TTM) 12.3%
GM 66.8%
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
PEN Yearly Profit, Operating, Gross MarginsPEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PEN is destroying value.
PEN has less shares outstanding than it did 1 year ago.
PEN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for PEN has been reduced compared to a year ago.
PEN Yearly Shares OutstandingPEN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
PEN Yearly Total Debt VS Total AssetsPEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

PEN has an Altman-Z score of 19.77. This indicates that PEN is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of PEN (19.77) is better than 95.74% of its industry peers.
PEN has a debt to FCF ratio of 0.15. This is a very positive value and a sign of high solvency as it would only need 0.15 years to pay back of all of its debts.
PEN's Debt to FCF ratio of 0.15 is amongst the best of the industry. PEN outperforms 93.62% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that PEN is not too dependend on debt financing.
The Debt to Equity ratio of PEN (0.02) is better than 71.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.15
Altman-Z 19.77
ROIC/WACC0.85
WACC8.65%
PEN Yearly LT Debt VS Equity VS FCFPEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 6.73 indicates that PEN has no problem at all paying its short term obligations.
PEN has a better Current ratio (6.73) than 84.57% of its industry peers.
A Quick Ratio of 4.18 indicates that PEN has no problem at all paying its short term obligations.
PEN's Quick ratio of 4.18 is fine compared to the rest of the industry. PEN outperforms 77.66% of its industry peers.
Industry RankSector Rank
Current Ratio 6.73
Quick Ratio 4.18
PEN Yearly Current Assets VS Current LiabilitesPEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

8

3. Growth

3.1 Past

PEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.47%, which is quite impressive.
PEN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.23% yearly.
PEN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.61%.
Measured over the past years, PEN shows a quite strong growth in Revenue. The Revenue has been growing by 16.89% on average per year.
EPS 1Y (TTM)36.47%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%14.12%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%17.82%

3.2 Future

Based on estimates for the next years, PEN will show a very strong growth in Earnings Per Share. The EPS will grow by 24.42% on average per year.
Based on estimates for the next years, PEN will show a quite strong growth in Revenue. The Revenue will grow by 13.24% on average per year.
EPS Next Y31.54%
EPS Next 2Y33.19%
EPS Next 3Y30.6%
EPS Next 5Y24.42%
Revenue Next Year14.71%
Revenue Next 2Y14.46%
Revenue Next 3Y14.21%
Revenue Next 5Y13.24%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PEN Yearly Revenue VS EstimatesPEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
PEN Yearly EPS VS EstimatesPEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 80.35, which means the current valuation is very expensive for PEN.
Based on the Price/Earnings ratio, PEN is valued a bit cheaper than 65.96% of the companies in the same industry.
PEN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.31.
Based on the Price/Forward Earnings ratio of 57.28, the valuation of PEN can be described as expensive.
Based on the Price/Forward Earnings ratio, PEN is valued a bit cheaper than 67.55% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.56, PEN is valued quite expensively.
Industry RankSector Rank
PE 80.35
Fwd PE 57.28
PEN Price Earnings VS Forward Price EarningsPEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PEN is valued a bit cheaper than the industry average as 65.96% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, PEN is valued a bit cheaper than 71.28% of the companies in the same industry.
Industry RankSector Rank
P/FCF 74.84
EV/EBITDA 57.23
PEN Per share dataPEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PEN does not grow enough to justify the current Price/Earnings ratio.
PEN has a very decent profitability rating, which may justify a higher PE ratio.
PEN's earnings are expected to grow with 30.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.55
PEG (5Y)3.32
EPS Next 2Y33.19%
EPS Next 3Y30.6%

0

5. Dividend

5.1 Amount

PEN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PENUMBRA INC

NYSE:PEN (12/1/2025, 4:10:00 PM)

After market: 291.66 0 (0%)

291.66

-1.51 (-0.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-16 2026-02-16/amc
Inst Owners93.23%
Inst Owner Change6.17%
Ins Owners3.71%
Ins Owner Change6.85%
Market Cap11.42B
Revenue(TTM)1.33B
Net Income(TTM)164.03M
Analysts83.33
Price Target319.31 (9.48%)
Short Float %4.85%
Short Ratio4.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.92%
Min EPS beat(2)3.63%
Max EPS beat(2)4.22%
EPS beat(4)4
Avg EPS beat(4)9.67%
Min EPS beat(4)3.63%
Max EPS beat(4)23.86%
EPS beat(8)8
Avg EPS beat(8)11.2%
EPS beat(12)12
Avg EPS beat(12)25.5%
EPS beat(16)14
Avg EPS beat(16)17.71%
Revenue beat(2)2
Avg Revenue beat(2)2.8%
Min Revenue beat(2)2.56%
Max Revenue beat(2)3.05%
Revenue beat(4)4
Avg Revenue beat(4)1.89%
Min Revenue beat(4)0.28%
Max Revenue beat(4)3.05%
Revenue beat(8)6
Avg Revenue beat(8)0.73%
Revenue beat(12)10
Avg Revenue beat(12)1.17%
Revenue beat(16)12
Avg Revenue beat(16)1.31%
PT rev (1m)0.15%
PT rev (3m)-0.1%
EPS NQ rev (1m)-2.31%
EPS NQ rev (3m)-1.9%
EPS NY rev (1m)0%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)0.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 80.35
Fwd PE 57.28
P/S 8.56
P/FCF 74.84
P/OCF 56.18
P/B 8.41
P/tB 9.63
EV/EBITDA 57.23
EPS(TTM)3.63
EY1.24%
EPS(NY)5.09
Fwd EY1.75%
FCF(TTM)3.9
FCFY1.34%
OCF(TTM)5.19
OCFY1.78%
SpS34.06
BVpS34.7
TBVpS30.28
PEG (NY)2.55
PEG (5Y)3.32
Graham Number53.23
Profitability
Industry RankSector Rank
ROA 9.4%
ROE 12.07%
ROCE 10.97%
ROIC 7.37%
ROICexc 10.5%
ROICexgc 12.46%
OM 12.95%
PM (TTM) 12.3%
GM 66.8%
FCFM 11.44%
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.84%
ROICexc(5y)N/A
ROICexgc(3y)4.75%
ROICexgc(5y)N/A
ROCE(3y)4.43%
ROCE(5y)N/A
ROICexgc growth 3Y49.31%
ROICexgc growth 5Y-5.8%
ROICexc growth 3Y58%
ROICexc growth 5Y-7.52%
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
F-Score7
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.15
Debt/EBITDA 0.11
Cap/Depr 291.22%
Cap/Sales 3.8%
Interest Coverage 250
Cash Conversion 106.89%
Profit Quality 93.05%
Current Ratio 6.73
Quick Ratio 4.18
Altman-Z 19.77
F-Score7
WACC8.65%
ROIC/WACC0.85
Cap/Depr(3y)74.85%
Cap/Depr(5y)109.14%
Cap/Sales(3y)1.83%
Cap/Sales(5y)2.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.47%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%14.12%
EPS Next Y31.54%
EPS Next 2Y33.19%
EPS Next 3Y30.6%
EPS Next 5Y24.42%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%17.82%
Revenue Next Year14.71%
Revenue Next 2Y14.46%
Revenue Next 3Y14.21%
Revenue Next 5Y13.24%
EBIT growth 1Y54.5%
EBIT growth 3Y67.65%
EBIT growth 5Y12.66%
EBIT Next Year74.3%
EBIT Next 3Y39.57%
EBIT Next 5Y26.5%
FCF growth 1Y222.8%
FCF growth 3YN/A
FCF growth 5Y100.55%
OCF growth 1Y225.73%
OCF growth 3Y160.78%
OCF growth 5Y44.6%

PENUMBRA INC / PEN FAQ

What is the ChartMill fundamental rating of PENUMBRA INC (PEN) stock?

ChartMill assigns a fundamental rating of 6 / 10 to PEN.


Can you provide the valuation status for PENUMBRA INC?

ChartMill assigns a valuation rating of 4 / 10 to PENUMBRA INC (PEN). This can be considered as Fairly Valued.


What is the profitability of PEN stock?

PENUMBRA INC (PEN) has a profitability rating of 6 / 10.


What are the PE and PB ratios of PENUMBRA INC (PEN) stock?

The Price/Earnings (PE) ratio for PENUMBRA INC (PEN) is 80.35 and the Price/Book (PB) ratio is 8.41.


Can you provide the financial health for PEN stock?

The financial health rating of PENUMBRA INC (PEN) is 8 / 10.